An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 17-23

  Zhang, Qing Hai ^a   Zu, Xu Yu ^a   Cao, Ren Xian ^a   Liu, Jiang Hua ^a   Mo, Zhong Cheng ^a   Zeng, Ying ^a   Li, Yuan Bin ^a   Xiong, Sheng Lin ^a   Liu, Xing ^a   Liao, Duan Fang ^b   Yi, Guang Hui ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

COX 2; ENOS; HDL; PGI 2; PI3K; SR B1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APOLIPOPROTEIN A1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTACYCLIN; PROTEIN KINASE B; SCAVENGER RECEPTOR BI;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOLIPOPROTEIN A-I; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; ENDOTHELIAL CELLS; EPOPROSTENOL; HUMANS; LIPOPROTEINS, HDL; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SCAVENGER RECEPTORS, CLASS B;

EID: 84862831402     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.103     Document Type: Article

References (30)

1. Rauramaa R., Salonen J.T., Kukkonen-Harjula K., et al. Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle aged men. Br. Med. J. (Clin. Res. Ed.) 1984, 288:603-606.
2. Symons J.D. Longitudinal and cross-sectional studies of the relationship between 6-keto PGF1 alpha and high density lipoproteins. Prostaglandins Leukot. Essent. Fatty Acids 1990, 39:159-165.
3. Fleisher L.N., Tall A.R., Witte L.D., et al. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J. Biol. Chem. 1982, 257:6653-6655.
4. Spector A.A., Scanu A.M., Kaduce T.L., et al. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells. J. Lipid Res. 1985, 26:288-297.
5. Oravec S., Demuth K., Myara I., et al. The effect of high density lipoprotein subfractions on endothelial eicosanoid secretion. Thromb. Res. 1998, 92:65-71.
6. Pomerantz K.B., Fleisher L.N., Tall A.R., et al. Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I2 synthesis. J. Lipid Res. 1985, 26:1269-1276.
7. Escudero I., Martinez-Gonzalez J., Alonso R., et al. Experimental and interventional dietary study in humans on the role of HDL fatty acid composition in PGI2 release and Cox-2 expression by VSMC. Eur. J. Clin. Invest. 2003, 33:779-786.
8. Vinals M., Martinez-Gonzalez J., Badimon J.J., et al. HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler. Thromb. Vasc. Biol. 1997, 17:3481-3488.
9. Gonzalez-Diez M., Rodriguez C., Badimon L., et al. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin. Thromb. Haemost. 2008, 100:119-126.
10. Rodriguez C., Gonzalez-Diez M., Badimon L., et al. Sphingosine-1-phosphate: a bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Thromb. Haemost. 2009, 101:665-673.
11. Martinez-Gonzalez J., Escudero I., Badimon L. Simvastatin potenciates PGI(2) release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL. Atherosclerosis. 2004, 174:305-313.
12. Norata G.D., Callegari E., Inoue H., et al. HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler. Thromb. Vasc. Biol. 2004, 24:871-877.
13. Connelly M.A. SR-BI-mediated HDL cholesteryl ester delivery in the adrenal gland. Mol. Cell. Endocrinol. 2009, 300:83-88.
14. Mineo C., Deguchi H., Griffin J.H., et al. Endothelial and antithrombotic actions of HDL. Circ. Res. 2006, 98:1352-1364.
15. Mineo C., Shaul P.W. HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action. Trends Cardiovasc. Med. 2003, 13:226-231.
16. Seetharam D., Mineo C. Gormley AK et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I, Circ Res. 2006, 98:63-72.
17. Guo J.S., Cho C.H., Wang J.Y., et al. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. Eur. J. Pharmacol. 2006, 536:301-308.
18. Liu D., Ji L., Tong X., et al. Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1. Am. J. Physiol. Cell Physiol. 2011, 301:C739-748.
19. Yuhanna I.S., Zhu Y., Cox B.E., et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat. Med. 2001, 7:853-857.
20. Igarashi J., Michel T. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J. Biol. Chem. 2000, 275:32363-32370.
21. Kimura T., Tomura H., Mogi C., et al. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J. Biol. Chem. 2006, 281:37457-37467.
22. Tolle M., Pawlak A., Schuchardt M., et al. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1542-1548.
23. Perez-Sala D., Lamas S. Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid. Redox Signal. 2001, 3:231-248.
24. Honda S., Migita K., Hirai Y., et al. Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells. Biochem. Biophys. Res. Commun. 2000, 268:928-931.
25. Park S.W., Lee S.G., Song S.H., et al. The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int. J. Cancer 2003, 107:729-738.
26. Liao P.L., Cheng Y.W., Li C.H., et al. Cholesterol-3-beta,5-alpha,6-beta-triol induced PI(3)K-Akt-eNOS-dependent cyclooxygenase-2 expression in endothelial cells. Toxicol. Lett. 2009, 190:172-178.
27. Ptasinska A., Wang S., Zhang J., et al. Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway. FASEB J. 2007, 21:950-961.
28. Wang S., Zhang J., Zhang Y., et al. Nitric oxide-p38 MAPK signaling stabilizes mRNA through AU-rich element-dependent and -independent mechanisms. J. Leukoc. Biol. 2008, 83:982-990.
29. Boddupalli C.S., Ghosh S., Rahim S.S., et al. Nitric oxide inhibits interleukin-12 p40 through p38 MAPK-mediated regulation of calmodulin and c-rel. Free Radic Biol Med. 2007, 42:686-697.
30. Browning D.D., McShane M.P., Marty C., et al. Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase. J. Biol. Chem. 2000, 275:2811-2816.